| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778146 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2018 | 17 Pages |
Abstract
This preliminary study shows that MRgFUS can be a feasible treatment option for FIGO class 1 uterine fibroids. Shrinkage of fibroids by MRgFUS can obviate or facilitate subsequent surgical intervention in selected cases.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Roy Mashiach, Yael Inbar, Jaron Rabinovici, Aya Mohr Sasson, Aviva Alagem-Mizrachi, Ronit Machtinger,